Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35206995)
Watch
English
Treatment of Alzheimer's disease: current status and new perspectives.
scientific article
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
title
Treatment of Alzheimer's disease: current status and new perspectives
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
main subject
Alzheimer's disease
0 references
author
Elio Scarpini
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
Howard Feldman
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
Philip Scheltens
series ordinal
2
object named as
Philip Scheltens
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
publication date
1 September 2003
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
published in
Lancet Neurology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
volume
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
issue
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
page(s)
539-547
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
cites work
The cholinergic hypothesis of geriatric memory dysfunction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The cholinergic hypothesis--ten years on.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment strategies for Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicotinic acetylcholine binding sites in Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholinergic strategies for Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholinergic markers in elderly patients with early signs of Alzheimer disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholinesterase inhibitors: A new class of psychotropic compounds
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Galantamine: a review of its use in Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changes in brain cholinesterases in senile dementia of Alzheimer type
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Switching previous therapies for Alzheimer's disease to galantamine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NMDA receptors: from genes to channels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A synaptic model of memory: long-term potentiation in the hippocampus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Excitatory amino acids and Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Memantine in moderate-to-severe Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Presenilin, Notch, and the genesis and treatment of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A portrait of Alzheimer secretases--new features and familiar faces
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Secretases as targets for the treatment of Alzheimer's disease: the prospects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Presenilins as therapeutic targets for the treatment of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BACE1 is the major beta-secretase for generation of Abeta peptides by neurons
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cerebral hemorrhage after passive anti-Abeta immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A liposome-based therapeutic vaccine against beta -amyloid plaques on the pancreas of transgenic NORBA mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Towards Alzheimer's beta-amyloid vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A safer vaccine for Alzheimer's disease?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protein misfolding and disease; protein refolding and therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of Copper Interactions with Alzheimer Amyloid β Peptides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Copper, iron and zinc in Alzheimer's disease senile plaques
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflammation and Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of Alzheimer's disease and duration of NSAID use.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclo-oxygenase inhibitors and Alzheimer's: are we well ADAPTed?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical trial of indomethacin in Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized pilot study of nimesulide treatment in Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic epidemiology of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Statins and the risk of dementia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900502-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1474-4422(03)00502-7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
PubMed publication ID
12941576
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12941576
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941576%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit